News

Some breaking news from Oklahoma’s bioscience community: Oklahoma companies Moleculera Labs and Lipid Biologics are among a select few chosen to make their pitch to potential investors in Startup Stadium competition at the upcoming BIO show June 4-7 in Boston. Congratulations!Read more

Copyright © 2017, The Oklahoma Publishing Co. Oklahoma City’s Moleculera Labs Inc., an autoimmune neurobiology company, said Monday that a key patent has been issued covering the company’s method of identifying whether someone’s neurologic or psychiatric symptoms could be caused by an autoimmune dysfunction. The patent covers Moleculera’s methods of diagnosing pediatric acute-onset neuropsychiatric syndromeRead more

By Jim Stafford Copyright © 2017, The Oklahoma Publishing Co. In his second book, “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies,” Craig Shimasaki, Ph.D., titles one section “Learning from Failure.” “Failure is not a person or way of life; failure is an event,” Shimasaki said. “Interestingly, you learn immeasurably more from things that don’tRead more

Gutenberg adapted the principles of the wine press and used it as the foundation of the first printing press. His innovation became a perfect example of a concept called exaptation, which is taking an existing idea and repurposing it for use as something else. That’s the concept behind Oklahoma City’s Exaptive, a startup with a mission to facilitate serendipity. Exaptive does that by enabling the manipulation of large amounts of data so that diverse, disparate data sets can be synthesized, analyzed, and used as the foundation for new ideas.

For OU graduate student Amanda Curtis, the 2016 BIO show required some unique multi-tasking skills. Curtis greeted visitors to the Oklahoma exhibition booth, participated in Oklahoma Bioscience networking events and sat in on multiple partnering meetings with her colleagues from OU’s Office of Technology Development. All in a day’s work.

An Emerging Tech Center: Oklahoma City notable home-grown startups in Innovation Magazine Copyright © 2016 | Innovation America Accele BioPharma (founded in 2011) — Biotechnology business accelerator located in the University Research Park, formed to create a capital-efficient mechanism to identify, finance and manage groundbreaking early stage life science technologies. http://accelebio.com Analytical Research Laboratories/DNA Solutions/The KupiecRead more

Increasing evidence points to a relationship between certain bacterial infections and autoimmune attacks that can disrupt normal neurologic functioning, according to researchers at Moleculera Labs.

New year is a time to seize momentum on diversifying Oklahoma’s economy By Scott Meacham Copyright © 2015, The Oklahoma Publishing Company It’s that time of the year again — a time for facing forward while looking back at what has occurred over the past year. In the world of startups, there’s no time toRead more

Moleculera Labs Inc. has received renewal of Commission on Office Laboratories Accreditation certification.

By staff writers Courtesy of The Journal Record OKLAHOMA CITY – Moleculera Labs has been awarded a two-year $300,000 matching grant from the Oklahoma Center for the Advancement of Science and Technology. The grant supports the development and clinical validation of new diagnostic testing panels to identify autoantibodies directed against neuronal antigens in patients experiencingRead more

Moleculera Labs Inc. recently received a $1.06 million investment from i2E Inc., SeedStep Angel investors and other investors.

i2E, Inc., recently led a $1.06 million investment in Oklahoma City-based Moleculera Labs, Inc., through its Accelerate Oklahoma! Fund.

Moleculera provides personalized clinical testing services using the Cunningham Panel to help physicians diagnose children thought to be suffering from neurologic conditions.

The i2E Seed Capital Fund investment in Moleculera Labs shows that Oklahoma does have a continuum of investment capital in Oklahoma for early stage companies.

Learn about how Moleculera Labs has developed a series of tests for PANDAS and other neurological conditions on this week’s statewide Oklahoma Innovations radio show.

i2E recently closed a $700,000 investment in Moleculera Labs through its Oklahoma Seed Capital Fund, which led a $1.84 million financing round in the Oklahoma City-based company.

i2E, Inc., recently closed a $700,000 investment in Moleculera Labs, Inc., through its Oklahoma Seed Capital Fund, which led a $1.84 million financing round in the Oklahoma City-based company.

Through its Oklahoma Seed Capital Fund, i2E Inc. recently closed a $700,000 investment in Moleculera Labs Inc., which led a $1.84 million financing round in the Oklahoma City-based company.

Moleculera Labs opened its doors for business in late April, and in the first 90 days, business plan milestones are already being met.

Moleculera Labs won the overall award at The Journal Record’s Innovator of the Year event honoring business innovation Thursday night.